Search results
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and...
KOLR - KSFX Ozarks· 2 days agoProtalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by ...
Machine Learning Approach Helps Identify New Rare Variants Linked to Heart Disease
GenomeWeb News· 1 day agoResearchers from the Icahn School of Medicine at Mount Sinai used a new computational method to identify rare and ultra-rare coding variants related to coronary artery disease (CAD) risk in ...
Statins: Millions of People on the Medications May Not Need Them
Healthline· 2 days agoA new analysis re-evaluates statins and who should use them. Statins are widely used to help lower...